Stock Information

Firm Analyst
BTIG
Sean Lavin
Canaccord Genuity
Kyle Rose
Stifel
Rick Wise
UBS
Matt Miksic

Obalon Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Obalon Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Obalon Therapeutics or its management. Obalon Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

IMPORTANT SAFETY INFORMATION
The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. The most common side effects reported were mild abdominal pain and nausea which typically resolved within two weeks. You must take daily acid-blocking medicine prescribed by your doctor. For full Important Safety Information click onSafety Information and Patient Labeling